Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia

Objective:Gynecomastia is defined as a benign proliferation of male breast glandular tissue. Its prevalence during puberty varies between 50-60% and is also common in neonatal and elderly males. It develops mainly due to the disequilibrium between estrogen and androgen activity in breast tissue, whe...

Full description

Bibliographic Details
Main Authors: Miłosz Lorek, Dominika Tobolska-Lorek, Barbara Kalina-Faska, Aleksandra Januszek-Trzciakowska, Aneta Gawlik
Format: Article
Language:English
Published: Galenos Yayincilik 2019-12-01
Series:JCRPE
Subjects:
Online Access: http://www.jcrpe.org/archives/archive-detail/article-preview/clinical-and-biochemical-phenotype-of-adolescent-m/27598
_version_ 1797920155015053312
author Miłosz Lorek
Dominika Tobolska-Lorek
Barbara Kalina-Faska
Aleksandra Januszek-Trzciakowska
Aneta Gawlik
author_facet Miłosz Lorek
Dominika Tobolska-Lorek
Barbara Kalina-Faska
Aleksandra Januszek-Trzciakowska
Aneta Gawlik
author_sort Miłosz Lorek
collection DOAJ
description Objective:Gynecomastia is defined as a benign proliferation of male breast glandular tissue. Its prevalence during puberty varies between 50-60% and is also common in neonatal and elderly males. It develops mainly due to the disequilibrium between estrogen and androgen activity in breast tissue, where estradiol (E2) binds to estrogen receptors and stimulates ductal and glandular cells. The aim of this work was to investigate the relationship between sex hormone alterations and the natural history of gynecomastia.Methods:Participants in this study were young males referred to an outpatient clinic, between January 2011 and February 2016, with breast enlargement. Thyroid function, liver function, hormone concentrations and tumor markers were measured and anthropometric assessment was conducted.Results:Subjects comprised 93 males, aged 9 to 18 (mean±standard deviation age 13.8±2.6) years. In 63 of 93 (67.7%) the gynecomastia was confirmed and 28 were followed-up for a median period of three months. None of the boys showed any reduction in breast size during follow-up. There was no correlation between body mass index Z-score and breast size. Breast enlargement progressed in nine boys (32.1%). A positive correlation between estrogen to testosterone (E2/TTE) ratio and Tanner B stage (r=0.47; p=0.034) was observed.Conclusion:The E2/TTE ratio may be a helpful tool in diagnosing gynecomastia. Altered E2/TTE ratio might be responsible for a proportion of cases described previously as idiopathic. Additionally, weight loss does not imply reduction of breast size in boys. Nonetheless it should be the first step in the management of prolonged gynecomastia.
first_indexed 2024-04-10T13:58:06Z
format Article
id doaj.art-c71959fd6dc141e1a57b8d60bbae1448
institution Directory Open Access Journal
issn 1308-5727
1308-5735
language English
last_indexed 2024-04-10T13:58:06Z
publishDate 2019-12-01
publisher Galenos Yayincilik
record_format Article
series JCRPE
spelling doaj.art-c71959fd6dc141e1a57b8d60bbae14482023-02-15T16:10:25ZengGalenos YayincilikJCRPE1308-57271308-57352019-12-0111438839410.4274/jcrpe.galenos.2019.2019.002713049054Clinical and Biochemical Phenotype of Adolescent Males with GynecomastiaMiłosz Lorek0Dominika Tobolska-Lorek1Barbara Kalina-Faska2Aleksandra Januszek-Trzciakowska3Aneta Gawlik4 Medical University of Silesia Faculty of Medicine, Department of Pediatrics and Pediatric Endocrinology, Katowice, Poland Medical University of Silesia Faculty of Medicine, Department of Pediatrics and Pediatric Endocrinology, Katowice, Poland Medical University of Silesia Faculty of Medicine, Department of Pediatrics and Pediatric Endocrinology, Katowice, Poland Medical University of Silesia Faculty of Medicine, Department of Pediatrics and Pediatric Endocrinology, Katowice, Poland Medical University of Silesia Faculty of Medicine, Department of Pediatrics and Pediatric Endocrinology, Katowice, Poland Objective:Gynecomastia is defined as a benign proliferation of male breast glandular tissue. Its prevalence during puberty varies between 50-60% and is also common in neonatal and elderly males. It develops mainly due to the disequilibrium between estrogen and androgen activity in breast tissue, where estradiol (E2) binds to estrogen receptors and stimulates ductal and glandular cells. The aim of this work was to investigate the relationship between sex hormone alterations and the natural history of gynecomastia.Methods:Participants in this study were young males referred to an outpatient clinic, between January 2011 and February 2016, with breast enlargement. Thyroid function, liver function, hormone concentrations and tumor markers were measured and anthropometric assessment was conducted.Results:Subjects comprised 93 males, aged 9 to 18 (mean±standard deviation age 13.8±2.6) years. In 63 of 93 (67.7%) the gynecomastia was confirmed and 28 were followed-up for a median period of three months. None of the boys showed any reduction in breast size during follow-up. There was no correlation between body mass index Z-score and breast size. Breast enlargement progressed in nine boys (32.1%). A positive correlation between estrogen to testosterone (E2/TTE) ratio and Tanner B stage (r=0.47; p=0.034) was observed.Conclusion:The E2/TTE ratio may be a helpful tool in diagnosing gynecomastia. Altered E2/TTE ratio might be responsible for a proportion of cases described previously as idiopathic. Additionally, weight loss does not imply reduction of breast size in boys. Nonetheless it should be the first step in the management of prolonged gynecomastia. http://www.jcrpe.org/archives/archive-detail/article-preview/clinical-and-biochemical-phenotype-of-adolescent-m/27598 gynecomastiapubertyestradioltestosteroneratio
spellingShingle Miłosz Lorek
Dominika Tobolska-Lorek
Barbara Kalina-Faska
Aleksandra Januszek-Trzciakowska
Aneta Gawlik
Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
JCRPE
gynecomastia
puberty
estradiol
testosterone
ratio
title Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
title_full Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
title_fullStr Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
title_full_unstemmed Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
title_short Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia
title_sort clinical and biochemical phenotype of adolescent males with gynecomastia
topic gynecomastia
puberty
estradiol
testosterone
ratio
url http://www.jcrpe.org/archives/archive-detail/article-preview/clinical-and-biochemical-phenotype-of-adolescent-m/27598
work_keys_str_mv AT miłoszlorek clinicalandbiochemicalphenotypeofadolescentmaleswithgynecomastia
AT dominikatobolskalorek clinicalandbiochemicalphenotypeofadolescentmaleswithgynecomastia
AT barbarakalinafaska clinicalandbiochemicalphenotypeofadolescentmaleswithgynecomastia
AT aleksandrajanuszektrzciakowska clinicalandbiochemicalphenotypeofadolescentmaleswithgynecomastia
AT anetagawlik clinicalandbiochemicalphenotypeofadolescentmaleswithgynecomastia